Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04626778 · ClinicalTrials.gov registry record · Phase 2
Clinical Efficacy of Single-Use of Peroxyl Mouthwash for Reducing Bacteria in Saliva and Bioaerosol Contamination
A Phase 2 study, sponsored by Colgate Palmolive.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
NCT04626778 is a Phase 2 study that has completed, run by Colgate Palmolive. The registered enrollment target is 100 participants.
The verdict
NCT04626778, a Phase 2 study, has completed, sponsored by Colgate Palmolive.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
Study Summary
To evaluate the anti-bacterial, pre-procedural, clinical efficacy of Peroxyl mouthwash (1.5% hydrogen peroxide) in saliva and the reduction of bioaerosol contamination as compared to a matching placebo mouthwash (0.0% hydrogen peroxide)
Interventions
- DRUG Peroxyl Mouthwash
- DRUG Placebo Mouthwash
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-10-08 |
| Est. Completion | 2020-12-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04626778
The ClinicalTrials.gov registry entry for NCT04626778 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colgate Palmolive, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Peroxyl Mouthwash is the first listed.
NCT04626778 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04626778 about?
NCT04626778 is a clinical study titled "Clinical Efficacy of Single-Use of Peroxyl Mouthwash for Reducing Bacteria in Saliva and Bioaerosol Contamination". To evaluate the anti-bacterial, pre-procedural, clinical efficacy of Peroxyl mouthwash (1.5% hydrogen peroxide) in saliva and the reduction of bioaerosol contamination as compared to a matching placebo mouthwash (0.0% hydrogen peroxide)
What is the current status of trial NCT04626778?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2020-10-08. Estimated completion is 2020-12-15.
What interventions are being tested in trial NCT04626778?
The interventions under investigation include: Peroxyl Mouthwash (DRUG), Placebo Mouthwash (DRUG).
Who is sponsoring clinical trial NCT04626778?
This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.